State seeking return on stem cell research investment;
<h3>Senate panel eyes conditional grants</h3><p class="source">The San Diego Union-Tribune</p>
<p>"In case of unreasonable pricing by drug companies the state needs to have march-in rights that allow it bring the prices down to a reasonable level," said John Simpson, of the Foundation for Taxpayer & Consumer Rights in Santa Monica.</p>
